Uniphos Enterprises Limited
NSE: UNIENTERMarket Closed • NSE
Day range
52 week range
Uniphos Enterprises Limited closed at INR87.41 (+1.4%) on volume 0.73x its 20-day average, trading 44.68% below its 52-week high.
2026-Q1
Q1 FY2026 Financial Results
PAT moved +30.4% QoQ
2026-07-17
DIVIDEND Announced
Dividend - Rs 3.50 Per Share
2025-08-29
DIVIDEND Announced
Dividend - Re 0.50 Per Share
Revenue and PAT bars use independent scales to make their year-on-year direction readable.
Complete reported financial history · Values use the company's reporting currency
Hover over the chart for exact reported values. Percentage lines use the right-hand axis.
A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.
Strengths
Established operational history in the sector
Active institutional participation
Risks
Subject to cyclical raw material and macro industry pressures
Bull case
Market Leadership: Established operational scale in Chemicals.
Bear case
Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.
Flip condition
Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.
Ownership distribution
Category trends
Hover over a period for exact holdings
Complete dividend, bonus, split, rights and other action history
| Record date | Corporate action | Information | Announcement date | Ex-date |
|---|---|---|---|---|
| 17 Jul 2026 | Dividend | ₹3.50 / share | — | 17 Jul 2026 |
| 29 Aug 2025 | Dividend | ₹0.50 / share | — | 29 Aug 2025 |
| — | Dividend | ₹5.70 / share | — | 06 Sept 2024 |
| — | Dividend | ₹6.50 / share | — | 11 Aug 2023 |
| — | Dividend | ₹5.65 / share | — | 04 Aug 2022 |
| — | Dividend | ₹3.40 / share | — | 29 Jul 2021 |
| — | Annual General Meeting | Annual General Meeting | — | 09 Aug 2018 |
| — | Annual General Meeting | Annual General Meeting | — | 22 Jun 2017 |
| — | Annual General Meeting | Annual General Meeting | — | 16 Jun 2016 |
| — | Annual General Meeting | Annual General Meeting | — | 16 Sept 2015 |
Traded volume and delivery percentage across the latest 20 sessions
Compare valuation, latest quarterly performance and year-on-year growth
| Company name | Market cap ₹ Cr | P/E ratio | Dividend yield % | Quarterly sales ₹ Cr | Profit after tax ₹ Cr | Sales growth % | Profit growth % |
|---|---|---|---|---|---|---|---|
 UltraTech Cement LimitedULTRACEMCO Open analysis | ₹3.21L | 37.59 | 2.21% | ₹25,799.47 | ₹2,982.76 | +11.86% | +20.17% |
 JSW Steel LimitedJSWSTEEL Open analysis | ₹2.97L | 12.05 | 0.59% | ₹47,364.00 | ₹4,651.00 | +11.55% | +112.96% |
 Hindustan Zinc LimitedHINDZINC Open analysis | ₹2.28L | 13.37 | 2.07% | ₹13,687.00 | ₹5,425.00 | +77.22% | +146.14% |
 Asian Paints LimitedASIANPAINT Open analysis | ₹2.24L | 46.94 | 1.17% | ₹10,541.94 | ₹1,539.25 | +17.94% | +39.96% |
 Tata Steel LimitedTATASTEEL Open analysis | ₹2.19L | 19.83 | 2.27% | ₹60,794.00 | ₹2,385.00 | +14.32% | +18.83% |
 Hindalco Industries LimitedHINDALCO Open analysis | ₹2.02L | 12.32 | 0.56% | ₹84,825.00 | ₹7,013.00 | +32.06% | +75.15% |
 Grasim Industries LimitedGRASIM Open analysis | ₹1.98L | 34.82 | 0.35% | ₹11,794.71 | ₹246.65 | -70.60% | -82.61% |
 Solar Industries India LimitedSOLARINDS Open analysis | ₹1.81L | 90.93 | 0.06% | ₹3,668.00 | ₹666.00 | +70.29% | +88.67% |
Incorporated in 1969, Uniphos Enterprises Ltd is in the business of trading of chemicals and other products[1]
IndiaBasic Materials
Is Uniphos Enterprises Limited Shariah compliant?
Uniphos Enterprises Limited is currently screened as Pending Data under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Interest-bearing debt or Market Cap data unavailable for ratio screening. Financial ratio screening incomplete due to missing balance sheet or market cap data.
What is Uniphos Enterprises Limited's current valuation relative to peers?
Uniphos Enterprises Limited trades at a P/E of 30.0x compared to the sector median of 21.9x, and a Price-to-Book of 0.2x.
Is the company financially healthy?
The company has a Debt-to-Equity ratio of zero debt. Interest coverage is comfortable.
What are the historical revenue and profit growth rates?
Over the past 5 years, revenue compounded at steady rates while net profit growth averaged consistent levels.
Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.
Market data may be delayed. Quote date: 2026-10-16. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.